NEW YORK, May 28, 2018 /PRNewswire/ -- Rosen Law Firm, a global
investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Myriad
Genetics, Inc. (NASDAQ: MYGN) from August 13, 2014 through March 12,
2018, inclusive. The lawsuit seeks to recover damages for Myriad investors under the federal securities laws.
To join the Myriad class action, go to http://rosenlegal.com/cases-1326.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or zhalper@rosenlegal.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants made materially false and/or misleading statements and/or failed to disclose that: (1)
Myriad was submitting false or otherwise improper claims for payment under Medicare and Medicaid for Myriad's hereditary cancer
testing; (2) the foregoing conduct would foreseeably subject Myriad to heightened regulatory scrutiny and/or enforcement action;
(3) Myriad's revenues from its hereditary cancer testing were in part the product of improper conduct and unlikely to be
sustainable; and (4) as a result, Myriad's public statements were materially false and misleading at all relevant times. When the
true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than
June 19, 2018. A lead plaintiff is a representative party acting on behalf of other class members
in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1326.html or to discuss your rights or
interests regarding this class action, please contact Phillip Kim, Esq. or Zachary Halper, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or zhalper@rosenlegal.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and
shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of
securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
zhalper@rosenlegal.com
www.rosenlegal.com
View original content:http://www.prnewswire.com/news-releases/mygn-case-notice-rosen-law-firm-announces-filing-of-securities-class-action-lawsuit-against-myriad-genetics-inc--mygn-300655291.html
SOURCE Rosen Law Firm